
1. malar j. 2016 jan 11;15:19. doi: 10.1186/s12936-015-1069-5.

prevalence molecular characterization g6pd deficiency two plasmodium
vivax endemic areas venezuela: predominance african a-(202a/376g)
variant.

vizzi e(1), bastidas g(2)(3)(4), hidalgo m(5), colman l(6), pérez ha(7).

author information: 
(1)laboratorio de biología de virus, centro de microbiología biología celular, 
instituto venezolano de investigaciones científicas, apdo 21827, caracas, 1020-a,
venezuela. esmeralda.vizzi@gmail.com.
(2)laboratorio de biología de virus, centro de microbiología biología celular, 
instituto venezolano de investigaciones científicas, apdo 21827, caracas, 1020-a,
venezuela. bastidasprotozoo@hotmail.com.
(3)laboratorio de inmunoparasitología, centro de microbiología biología
celular, instituto venezolano de investigaciones científicas, apdo 21827,
caracas, 1020-a, venezuela. bastidasprotozoo@hotmail.com.
(4)departamento de salud pública, facultad de ciencias de la salud, universidad
de carabobo, valencia, edo. carabobo, venezuela. bastidasprotozoo@hotmail.com.
(5)laboratorio de inmunoparasitología, centro de microbiología biología
celular, instituto venezolano de investigaciones científicas, apdo 21827,
caracas, 1020-a, venezuela. mariana.hidalgo.r@gmail.com.
(6)laboratorio de inmunoparasitología, centro de microbiología biología
celular, instituto venezolano de investigaciones científicas, apdo 21827,
caracas, 1020-a, venezuela. laura.colman@gmail.com.
(7)laboratorio de inmunoparasitología, centro de microbiología biología
celular, instituto venezolano de investigaciones científicas, apdo 21827,
caracas, 1020-a, venezuela. hildaper@gmail.com.

background: glucose-6-phosphate dehydrogenase (g6pd) deficiency causes acute
haemolytic anaemia triggered oxidative drugs primaquine (pq), used for
plasmodium vivax malaria radical cure. however, many endemic areas vivax
malaria, patients treated pq without evaluation g6pd
status.
methods: g6pd deficiency genetic heterogeneity evaluated in
northeastern southeastern areas venezuela, cajigal (sucre state) and
sifontes (bolívar state) municipalities, respectively. blood samples 664
randomly recruited unrelated individuals screened g6pd activity a
quantitative method. mutation analysis exons 4-8 g6pd gen performed on
dna isolated g6pd-deficient (g6pdd) subjects pcr-rflp direct dna
sequencing.
results: quantitative biochemical characterization revealed overall 24
(3.6%) subjects g6pdd (average g6pd enzyme activity 4.5 ± 1.2 u/g hb,
moderately deficient, class iii), dna analysis showed one two mutated
alleles 19 (79.2%). g6pd a-(202a/376g) variant only
detected 17 (70.8%) individuals, 13 hemizygous males four
heterozygous females. two males carried 376a → g mutation. other
mutation found analysed exons.
conclusions: g6pdd prevalence low one shown nearby
countries. study contributes knowledge genetic background of
venezuelan population, especially living malaria-endemic areas.
despite high degree genetic mixing described venezuelan population, 
net predominance mild african g6pd a-(202a/376g) variant observed
among g6pdd subjects, suggesting significant flow g6pd genes africa 
americas, almost certainly introduced african and/or spanish immigrants
during colonization. data suggest 1:27 individuals 
studied population could g6pdd therefore risk haemolysis under
precipitating factors. information pq effect g6pdd individuals carrying 
mild variant limited, since regimen 45 mg weekly dose for
prevention malaria relapse seem causing clinically significant 
haemolysis people g6pd a-variant, reasoned weighing of
risk-benefit use venezuela done, implementing public
health strategies control elimination.

doi: 10.1186/s12936-015-1069-5 
pmcid: pmc4710037
pmid: 26753754  [indexed medline]

